Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1608166rdf:typepubmed:Citationlld:pubmed
pubmed-article:1608166lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:1608166lifeskim:mentionsumls-concept:C1522565lld:lifeskim
pubmed-article:1608166lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1608166lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:1608166lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:1608166lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:1608166lifeskim:mentionsumls-concept:C0456904lld:lifeskim
pubmed-article:1608166pubmed:issue5lld:pubmed
pubmed-article:1608166pubmed:dateCreated1992-7-17lld:pubmed
pubmed-article:1608166pubmed:abstractTextA 61-year-old man suffering from compression fracture of the first lumbar vertebra was scheduled for anterior and posterior spinal fusion. Anesthesia was maintained with enflurane, nitrous oxide in oxygen and fentanyl. When his position was changed from right lateral to supine position, ventricular fibrillation (VF) occurred. The operation was discontinued and he was taken into ICU receiving cardiopulmonary resuscitation. Despite ordinary therapies including DC-shock and lidocaine infusion, Vf and defibrillation recurred more than 20 times for the first two hours. Electrocardiogram showed elevation of ST-T segments in II, III, aVF and V1-V3 leads. Because no effective treatment was found, we attempted to use glucose-insulin-potassium mixture, by which Vf stopped. Electrocardiogram taken on the following day showed abnormal Q wave in II, III and aVF leads, and the patient was diagnosed as having had acute myocardial infarction. On the fifth postoperative day, the patient was returned to the ward without neurological deficits. We conclude that glucose-insulin-potassium infusion is a beneficial therapy for Vf, which is resistant to ordinary treatments.lld:pubmed
pubmed-article:1608166pubmed:languagejpnlld:pubmed
pubmed-article:1608166pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1608166pubmed:citationSubsetIMlld:pubmed
pubmed-article:1608166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1608166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1608166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1608166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1608166pubmed:statusMEDLINElld:pubmed
pubmed-article:1608166pubmed:monthMaylld:pubmed
pubmed-article:1608166pubmed:issn0021-4892lld:pubmed
pubmed-article:1608166pubmed:authorpubmed-author:KuramitsuSSlld:pubmed
pubmed-article:1608166pubmed:authorpubmed-author:ShimizuKKlld:pubmed
pubmed-article:1608166pubmed:authorpubmed-author:TamuraHHlld:pubmed
pubmed-article:1608166pubmed:authorpubmed-author:YamasakiTTlld:pubmed
pubmed-article:1608166pubmed:authorpubmed-author:MatayoshiYYlld:pubmed
pubmed-article:1608166pubmed:authorpubmed-author:MuranakaKKlld:pubmed
pubmed-article:1608166pubmed:issnTypePrintlld:pubmed
pubmed-article:1608166pubmed:volume41lld:pubmed
pubmed-article:1608166pubmed:ownerNLMlld:pubmed
pubmed-article:1608166pubmed:authorsCompleteYlld:pubmed
pubmed-article:1608166pubmed:pagination850-5lld:pubmed
pubmed-article:1608166pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:meshHeadingpubmed-meshheading:1608166-...lld:pubmed
pubmed-article:1608166pubmed:year1992lld:pubmed
pubmed-article:1608166pubmed:articleTitle[A beneficial effect of glucose-insulin-potassium infusion for intractable ventricular fibrillation--a case of intraoperative myocardial infarction].lld:pubmed
pubmed-article:1608166pubmed:affiliationDepartment of Anesthesia, Yamaguchi Central Hospital, Hofu.lld:pubmed
pubmed-article:1608166pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1608166pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1608166pubmed:publicationTypeReviewlld:pubmed
pubmed-article:1608166pubmed:publicationTypeCase Reportslld:pubmed